Tissue Engineering
Viable autologous semilunar heart valve can be created from stem cells
Published in Blood Weekly, August 11th, 2005
"An estimated 275 000 patients undergo heart valve replacement each year. However, existing solutions for valve replacement are complicated by the morbidity associated with lifelong anticoagulation of mechanical valves and the limited durability of bioprostheses.
"Recent advances in tissue engineering and our understanding of stem cell biology may provide a lifelong solution to these problems," wrote investigators in Scotland.
"Mesenchymal stem cells were isolated from ovine bone marrow and characterized by their morphology and antigen expression through...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2005-08-11)
More Articles from Blood Weekly
- Spinal Cord Injury
Neural SCs delivered to injured cervical spinal cord by intrathecal injection - Stem Cell Transplantation
Autologous mesenchymal stem cell transplantation improves recovery after stroke - Stem Cell Transplantation
CD34+ cell dose plays role in preventing late infections in pediatric SCT - Tissue Engineering
Autologous epidermal cells induce wound closure of neurotrophic ulcerations - Hemophilus ducreyi
H. ducreyi dsrA mutant killed by normal human serum initiated by IgM binding - Age-Related Macular Degeneration
Pharma company announces clinical program evaluating VEGF Trap - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
